Klinisk Biokemi i Norden · 3 2014
| 9
lity control and ethical implications of next genera-
tion sequencing when applied in the clinic. Should
we always communicate disease-linked mutations to
the patient? Is there a need for consensus on ethical
principles when we use Next Generation Sequencing?
The third day will have hematological and labora-
tory organization themes and opens with a plenary
session by Professor Ebba Nexö, Aarhus, who once
and for all will teach us how to diagnose B12 defi-
ciency. Seminars in the morning and in the after-
noon will cover the diagnosis of disorders of iron
metabolism and myeloproliferative disorders. Neuro-
chemistry in Mölndal, one of the leading laboratories
in the field, will host a seminar where international
experts will discuss biomarkers in neurodegenerative
diseases.
The future clinical laboratory is expected to rely
even more on collaborations between physicians,
laboratory technicians and clinical chemists. Two
seminars will therefore illustrate good examples of
novel ways to organize clinical laboratories and novel
ways to interact along the chain of events, from ana-
lysis to medical decisions. Education that will be an
integral part of this development will be discussed in
a seminar on the last day.
As the grand finale of the third day, the members of
the organizing committee have planned a spectacular
gala dinner on the theme of “Glitter & Glamour” at a
restaurant located close to the congress hall. Be there
or be square!
We have saved some of the highlights to the last
day. Professor Ulf Gyllensten, Director of the Natio-
nal Genomics Infrastructure, Uppsala, and an inter-
national expert in the field of molecular genomics will
give us his view of how new DNA-based technology
will change the medical profession. Professor Anders
Grubb from Malmö will present novel cystatin C
eGFR equations linked to an universal calibrator.
If you think that you understand the basis of can-
cer development, think again. Professor Ingemar
Ernberg, Stockholm, will discuss how mathematical
strange attractors now offer an explanation of how
cancers can be so stable and untreatable. We will
also learn about novel cancer biomarkers for ovarian
and lung cancer.
As usual, the programwill include seminars related
to the Astrup and Eldjarn Prizes. Posters will be on
display close to the seminar rooms in the congress
hall throughout the meeting. The best poster will
be highlighted in abstract presentations and guided
poster walks.
The meeting will also feature company-sponsored
lunch seminars and breakfast seminars. A newsletter,
covering the meeting highlights and interviews with
participants and speakers, will be published daily in
your smartphone.
Göteborg, Sweden's second largest city is located on
the west coast and is usually at its prime in the early
fall including top quality seafood and the possibility
to experience river ferries to view the city from the
water and the nearby archipelago. For more informa-
tion on Göteborg, the official visitor’s guide provides
good guidance
.
Information on the congress is available on the
website
. Here, you also can see
deadlines for registration as well as a backward-
running clock, showing the time left to the meeting.
Important dates
- June 2014 – Deadline for reduced congress fee
It is our mission to make you see the future of
laboratory medicine.
We hope to see you all in Göteborg!
